ArticleNature communications2018

DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models.

Yuki Kagoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.